{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:26:48Z","timestamp":1787239608637,"version":"build-2736575974"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA021765"],"award-info":[{"award-number":["CA021765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R35 CA197695"],"award-info":[{"award-number":["R35 CA197695"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>DNA methylation is tightly regulated during development and is stably maintained in healthy cells. In contrast, cancer cells are commonly characterized by a global loss of DNA methylation co-occurring with CpG island hypermethylation. In acute lymphoblastic leukemia (ALL), the commonest childhood cancer, perturbations of CpG methylation have been reported to be associated with genetic disease subtype and outcome, but data from large cohorts at a genome-wide scale are lacking. Here, we performed whole-genome bisulfite sequencing across ALL subtypes, leukemia cell lines and healthy hematopoietic cells, and show that unlike most cancers, ALL samples exhibit CpG island hypermethylation but minimal global loss of methylation. This was most pronounced in T cell ALL and accompanied by an exceptionally broad range of hypermethylation of CpG islands between patients, which is influenced by TET2 and DNMT3B. These findings demonstrate that ALL is characterized by an unusually highly methylated genome and provide further insights into the non-canonical regulation of methylation in cancer.<\/jats:p>","DOI":"10.1038\/s43018-022-00370-5","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T12:07:12Z","timestamp":1652962032000},"page":"768-782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Acute lymphoblastic leukemia displays a distinct highly methylated genome"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4783-3814","authenticated-orcid":false,"given":"Sara","family":"Hetzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1450-8924","authenticated-orcid":false,"given":"Alexandra L.","family":"Mattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Kretzmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2499-8261","authenticated-orcid":false,"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1678-5864","authenticated-orcid":false,"given":"Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7626-4043","authenticated-orcid":false,"given":"Kathryn G.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Litzow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Paietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5892-1553","authenticated-orcid":false,"given":"Elaine R.","family":"Mardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Downing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1850","authenticated-orcid":false,"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8646-7469","authenticated-orcid":false,"given":"Alexander","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"370_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng.2836","volume":"46","author":"M Jeong","year":"2014","unstructured":"Jeong, M. et al. Large conserved domains of low DNA methylation maintained by Dnmt3a. Nat. Genet. 46, 17\u201323 (2014).","journal-title":"Nat. Genet."},{"key":"370_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41580-019-0143-1","volume":"20","author":"EM Michalak","year":"2019","unstructured":"Michalak, E. M., Burr, M. L., Bannister, A. J. & Dawson, M. A. The roles of DNA, RNA and histone methylation in ageing and cancer. Nat. Rev. Mol. Cell Biol. 20, 573\u2013589 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"370_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1492-3","volume":"19","author":"J Su","year":"2018","unstructured":"Su, J. et al. Homeobox oncogene activation by pan-cancer DNA hypermethylation. Genome Biol. 19, 108 (2018).","journal-title":"Genome Biol"},{"key":"370_CR4","first-page":"1159","volume":"48","author":"AP Feinberg","year":"1988","unstructured":"Feinberg, A. P., Gehrke, C. W., Kuo, K. C. & Ehrlich, M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48, 1159\u20131161 (1988).","journal-title":"Cancer Res."},{"key":"370_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/bjc.1997.64","volume":"75","author":"P Cheng","year":"1997","unstructured":"Cheng, P. et al. Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis. Br. J. Cancer 75, 396\u2013402 (1997).","journal-title":"Br. J. Cancer"},{"key":"370_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/10520290009085128","volume":"75","author":"CJ Piyathilake","year":"2000","unstructured":"Piyathilake, C. J. et al. Immunohistochemical evaluation of global DNA methylation: comparison with in vitro radiolabeled methyl incorporation assay. Biotech. Histochem. 75, 251\u2013258 (2000).","journal-title":"Biotech. Histochem."},{"key":"370_CR7","doi-asserted-by":"crossref","unstructured":"The Blueprint Consortium. Quantitative comparison of DNA methylation assays for biomarker development and clinical applications. Nat. Biotechnol. 34, 726\u2013737 (2016).","DOI":"10.1038\/nbt.3605"},{"key":"370_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/ng.969","volume":"44","author":"BP Berman","year":"2011","unstructured":"Berman, B. P. et al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat. Genet. 44, 40\u201346 (2011).","journal-title":"Nat. Genet."},{"key":"370_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41588-018-0073-4","volume":"50","author":"W Zhou","year":"2018","unstructured":"Zhou, W. et al. DNA methylation loss in late-replicating domains is linked to mitotic cell division. Nat. Genet. 50, 591\u2013602 (2018).","journal-title":"Nat. Genet."},{"key":"370_CR10","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.cell.2020.07.030","volume":"182","author":"SE Johnstone","year":"2020","unstructured":"Johnstone, S. E. et al. Large-scale topological changes restrain malignant progression in colorectal cancer. Cell 182, 1474\u20131489 (2020).","journal-title":"Cell"},{"key":"370_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ccr.2014.02.010","volume":"25","author":"DA Russler-Germain","year":"2014","unstructured":"Russler-Germain, D. A. et al. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. Cancer Cell 25, 442\u2013454 (2014).","journal-title":"Cancer Cell"},{"key":"370_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature10866","volume":"483","author":"S Turcan","year":"2012","unstructured":"Turcan, S. et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479\u2013483 (2012).","journal-title":"Nature"},{"key":"370_CR13","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","volume":"363","author":"TJ Ley","year":"2010","unstructured":"Ley, T. J. et al. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 363, 2424\u20132433 (2010).","journal-title":"N. Engl. J. Med."},{"key":"370_CR14","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/leu.2011.326","volume":"26","author":"S Weissmann","year":"2012","unstructured":"Weissmann, S. et al. Landscape of TET2 mutations in acute myeloid leukemia. Leukemia 26, 934\u2013942 (2012).","journal-title":"Leukemia"},{"key":"370_CR15","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/leu.2014.94","volume":"28","author":"SM Greenblatt","year":"2014","unstructured":"Greenblatt, S. M. & Nimer, S. D. Chromatin modifiers and the promise of epigenetic therapy in acute leukemia. Leukemia 28, 1396\u20131406 (2014).","journal-title":"Leukemia"},{"key":"370_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1182\/asheducation.V2012.1.389.3798360","volume":"2012","author":"CG Mullighan","year":"2012","unstructured":"Mullighan, C. G. The molecular genetic makeup of acute lymphoblastic leukemia. Hematology Am. Soc. Hematol. Educ. Program 2012, 389\u2013396 (2012).","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"370_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-cancerbio-043020-110055","volume":"5","author":"TB Alexander","year":"2021","unstructured":"Alexander, T. B. & Mullighan, C. G. Molecular biology of childhood leukemia. Annu. Rev. Cancer Biol. 5, 95\u2013117 (2021).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"370_CR18","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1182\/blood-2017-06-743252","volume":"130","author":"SK Tasian","year":"2017","unstructured":"Tasian, S. K., Loh, M. L. & Hunger, S. P. Philadelphia chromosome-like acute lymphoblastic leukemia. Blood 130, 2064\u20132072 (2017).","journal-title":"Blood"},{"key":"370_CR19","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/ng.3691","volume":"48","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Nat. Genet. 48, 1481\u20131489 (2016).","journal-title":"Nat. Genet."},{"key":"370_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ng.2532","volume":"45","author":"L Holmfeldt","year":"2013","unstructured":"Holmfeldt, L. et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat. Genet. 45, 242\u2013252 (2013).","journal-title":"Nat. Genet."},{"key":"370_CR21","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1182\/blood-2009-04-214668","volume":"115","author":"L Milani","year":"2010","unstructured":"Milani, L. et al. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Blood 115, 1214\u20131225 (2010).","journal-title":"Blood"},{"key":"370_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.semcancer.2017.09.001","volume":"51","author":"J Nordlund","year":"2018","unstructured":"Nordlund, J. & Syvanen, A. C. Epigenetics in pediatric acute lymphoblastic leukemia. Semin. Cancer Biol. 51, 129\u2013138 (2018).","journal-title":"Semin. Cancer Biol."},{"key":"370_CR23","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1158\/0008-5472.CAN-06-3993","volume":"67","author":"KH Taylor","year":"2007","unstructured":"Taylor, K. H. et al. Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia. Cancer Res. 67, 2617\u20132625 (2007).","journal-title":"Cancer Res."},{"key":"370_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gr.083931.108","volume":"19","author":"L Milani","year":"2009","unstructured":"Milani, L. et al. Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation. Genome Res. 19, 1\u201311 (2009).","journal-title":"Genome Res."},{"key":"370_CR25","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1093\/hmg\/ddp354","volume":"18","author":"J Davidsson","year":"2009","unstructured":"Davidsson, J. et al. The DNA methylome of pediatric acute lymphoblastic leukemia. Hum. Mol. Genet. 18, 4054\u20134065 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"370_CR26","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1182\/blood-2009-06-227660","volume":"114","author":"DJ Stumpel","year":"2009","unstructured":"Stumpel, D. J. et al. Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. Blood 114, 5490\u20135498 (2009).","journal-title":"Blood"},{"key":"370_CR27","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1172\/JCI66203","volume":"123","author":"ME Figueroa","year":"2013","unstructured":"Figueroa, M. E. et al. Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia. J. Clin. Invest. 123, 3099\u20133111 (2013).","journal-title":"J. Clin. Invest."},{"key":"370_CR28","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2217\/epi-2016-0052","volume":"8","author":"P Wahlberg","year":"2016","unstructured":"Wahlberg, P. et al. DNA methylome analysis of acute lymphoblastic leukemia cells reveals stochastic de novo DNA methylation in CpG islands. Epigenomics 8, 1367\u20131387 (2016).","journal-title":"Epigenomics"},{"key":"370_CR29","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1093\/nar\/gkv103","volume":"43","author":"ST Lee","year":"2015","unstructured":"Lee, S. T. et al. Epigenetic remodeling in B-cell acute lymphoblastic leukemia occurs in two tracks and employs embryonic stem cell-like signatures. Nucleic Acids Res. 43, 2590\u20132602 (2015).","journal-title":"Nucleic Acids Res."},{"key":"370_CR30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1080\/15592294.2015.1078050","volume":"10","author":"M Almamun","year":"2015","unstructured":"Almamun, M. et al. Integrated methylome and transcriptome analysis reveals novel regulatory elements in pediatric acute lymphoblastic leukemia. Epigenetics 10, 882\u2013890 (2015).","journal-title":"Epigenetics"},{"key":"370_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/cam4.1917","volume":"8","author":"Z Haider","year":"2019","unstructured":"Haider, Z. et al. An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression. Cancer Med. 8, 311\u2013324 (2019).","journal-title":"Cancer Med."},{"key":"370_CR32","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1158\/2643-3230.BCD-20-0059","volume":"1","author":"J Roels","year":"2020","unstructured":"Roels, J. et al. Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia. Blood Cancer Discov. 1, 274\u2013289 (2020).","journal-title":"Blood Cancer Discov"},{"key":"370_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13072-019-0278-5","volume":"12","author":"CJ Poole","year":"2019","unstructured":"Poole, C. J., Lodh, A., Choi, J. H. & van Riggelen, J. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL. Epigenetics Chromatin 12, 41 (2019).","journal-title":"Epigenetics Chromatin"},{"key":"370_CR34","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts, K. G. et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N. Engl. J. Med. 371, 1005\u20131015 (2014).","journal-title":"N. Engl. J. Med."},{"key":"370_CR35","doi-asserted-by":"publisher","unstructured":"Flavahan, W. A., Gaskell, E. & Bernstein, B. E. Epigenetic plasticity and the hallmarks of cancer. Science https:\/\/doi.org\/10.1126\/science.aal2380 (2017).","DOI":"10.1126\/science.aal2380"},{"key":"370_CR36","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ng.865","volume":"43","author":"KD Hansen","year":"2011","unstructured":"Hansen, K. D. et al. Increased methylation variation in epigenetic domains across cancer types. Nat. Genet. 43, 768\u2013775 (2011).","journal-title":"Nat. Genet."},{"key":"370_CR37","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nature07107","volume":"454","author":"A Meissner","year":"2008","unstructured":"Meissner, A. et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766\u2013770 (2008).","journal-title":"Nature"},{"key":"370_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09828-0","volume":"10","author":"AB Brinkman","year":"2019","unstructured":"Brinkman, A. B. et al. Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation. Nat. Commun. 10, 1749 (2019).","journal-title":"Nat. Commun."},{"key":"370_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nbt.1533","volume":"27","author":"MP Ball","year":"2009","unstructured":"Ball, M. P. et al. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat. Biotechnol. 27, 361\u2013368 (2009).","journal-title":"Nat. Biotechnol."},{"key":"370_CR40","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/hmg\/ddq513","volume":"20","author":"D Aran","year":"2011","unstructured":"Aran, D., Toperoff, G., Rosenberg, M. & Hellman, A. Replication timing-related and gene body-specific methylation of active human genes. Hum. Mol. Genet. 20, 670\u2013680 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"370_CR41","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2014.07.028","volume":"26","author":"X Yang","year":"2014","unstructured":"Yang, X. et al. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell 26, 577\u2013590 (2014).","journal-title":"Cancer Cell"},{"key":"370_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature09165","volume":"466","author":"AK Maunakea","year":"2010","unstructured":"Maunakea, A. K. et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466, 253\u2013257 (2010).","journal-title":"Nature"},{"key":"370_CR43","doi-asserted-by":"publisher","unstructured":"Baylin, S. B. & Jones, P. A. Epigenetic determinants of cancer. Cold Spring Harb. Perspect. Biol. https:\/\/doi.org\/10.1101\/cshperspect.a019505 (2016).","DOI":"10.1101\/cshperspect.a019505"},{"key":"370_CR44","doi-asserted-by":"publisher","first-page":"e1003137","DOI":"10.1371\/journal.pgen.1003137","volume":"9","author":"S De","year":"2013","unstructured":"De, S. et al. Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity. PLoS Genet. 9, e1003137 (2013).","journal-title":"PLoS Genet."},{"key":"370_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7921","volume":"6","author":"H Pan","year":"2015","unstructured":"Pan, H. et al. Epigenomic evolution in diffuse large B-cell lymphomas. Nat. Commun. 6, 6921 (2015).","journal-title":"Nat. Commun."},{"key":"370_CR46","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/ng.3258","volume":"47","author":"J Liao","year":"2015","unstructured":"Liao, J. et al. Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells. Nat. Genet. 47, 469\u2013478 (2015).","journal-title":"Nat. Genet."},{"key":"370_CR47","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.molcel.2014.12.023","volume":"57","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation. Mol. Cell 57, 662\u2013673 (2015).","journal-title":"Mol. Cell"},{"key":"370_CR48","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/hmg\/10.13.1413","volume":"10","author":"DJ Smiraglia","year":"2001","unstructured":"Smiraglia, D. J. et al. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum. Mol. Genet. 10, 1413\u20131419 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"370_CR49","first-page":"1114","volume":"63","author":"MF Paz","year":"2003","unstructured":"Paz, M. F. et al. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 63, 1114\u20131121 (2003).","journal-title":"Cancer Res."},{"key":"370_CR50","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1136\/gut.2005.082933","volume":"55","author":"S Ogino","year":"2006","unstructured":"Ogino, S. et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 55, 1000\u20131006 (2006).","journal-title":"Gut"},{"key":"370_CR51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2217\/epi.14.74","volume":"7","author":"J Roessler","year":"2015","unstructured":"Roessler, J. et al. The CpG island methylator phenotype in breast cancer is associated with the lobular subtype. Epigenomics 7, 187\u2013199 (2015).","journal-title":"Epigenomics"},{"key":"370_CR52","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","volume":"17","author":"H Noushmehr","year":"2010","unstructured":"Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510\u2013522 (2010).","journal-title":"Cancer Cell"},{"key":"370_CR53","doi-asserted-by":"publisher","first-page":"8681","DOI":"10.1073\/pnas.96.15.8681","volume":"96","author":"M Toyota","year":"1999","unstructured":"Toyota, M. et al. CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA 96, 8681\u20138686 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"370_CR54","doi-asserted-by":"publisher","first-page":"e65373","DOI":"10.1371\/journal.pone.0065373","volume":"8","author":"M Borssen","year":"2013","unstructured":"Borssen, M. et al. Promoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemia. PLoS ONE 8, e65373 (2013).","journal-title":"PLoS ONE"},{"key":"370_CR55","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ng1950","volume":"39","author":"Y Schlesinger","year":"2007","unstructured":"Schlesinger, Y. et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet. 39, 232\u2013236 (2007).","journal-title":"Nat. Genet."},{"key":"370_CR56","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/ng1941","volume":"39","author":"M Widschwendter","year":"2007","unstructured":"Widschwendter, M. et al. Epigenetic stem cell signature in cancer. Nat. Genet. 39, 157\u2013158 (2007).","journal-title":"Nat. Genet."},{"key":"370_CR57","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature23891","volume":"549","author":"ZD Smith","year":"2017","unstructured":"Smith, Z. D. et al. Epigenetic restriction of extraembryonic lineages mirrors the somatic transition to cancer. Nature 549, 543\u2013547 (2017).","journal-title":"Nature"},{"key":"370_CR58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41576-020-00287-8","volume":"22","author":"A Parry","year":"2021","unstructured":"Parry, A., Rulands, S. & Reik, W. Active turnover of DNA methylation during cell fate decisions. Nat. Rev. Genet. 22, 59\u201366 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"370_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","volume":"562","author":"TB Alexander","year":"2018","unstructured":"Alexander, T. B. et al. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature 562, 373\u2013379 (2018).","journal-title":"Nature"},{"key":"370_CR60","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","volume":"51","author":"Z Gu","year":"2019","unstructured":"Gu, Z. et al. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat. Genet. 51, 296\u2013307 (2019).","journal-title":"Nat. Genet."},{"key":"370_CR61","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41588-017-0002-y","volume":"50","author":"N Verma","year":"2018","unstructured":"Verma, N. et al. TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells. Nat. Genet. 50, 83\u201395 (2018).","journal-title":"Nat. Genet."},{"key":"370_CR62","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/1471-2105-10-232","volume":"10","author":"Y Xi","year":"2009","unstructured":"Xi, Y. & Li, W. BSMAP: whole genome bisulfite sequence MAPping program. BMC Bioinf. 10, 232 (2009).","journal-title":"BMC Bioinf."},{"key":"370_CR63","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"370_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r38","volume":"15","author":"D Sun","year":"2014","unstructured":"Sun, D. et al. MOABS: model based analysis of bisulfite sequencing data. Genome Biol. 15, R38 (2014).","journal-title":"Genome Biol"},{"key":"370_CR65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"370_CR66","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290\u2013295 (2015).","journal-title":"Nat. Biotechnol."},{"key":"370_CR67","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat. Genet. 49, 1211\u20131218 (2017).","journal-title":"Nat. Genet."},{"key":"370_CR68","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"370_CR69","unstructured":"Kolde, R. Pheatmap: pretty heatmaps. R Package v.61, 1\u20137 (2012)."},{"key":"370_CR70","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"370_CR71","doi-asserted-by":"publisher","unstructured":"Hetzel, S., Giesselmann, P., Reinert, K., Meissner, A. & Kretzmer, H. RLM: Fast and simplified extraction of read-level methylation metrics from bisulfite sequencing data. Bioinformatics https:\/\/doi.org\/10.1093\/bioinformatics\/btab663 (2021).","DOI":"10.1093\/bioinformatics\/btab663"},{"key":"370_CR72","doi-asserted-by":"publisher","first-page":"18439","DOI":"10.1073\/pnas.2009316117","volume":"117","author":"W Ren","year":"2020","unstructured":"Ren, W. et al. Direct readout of heterochromatic H3K9me3 regulates DNMT1-mediated maintenance DNA methylation. Proc. Natl Acad. Sci. USA 117, 18439\u201318447 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"370_CR73","doi-asserted-by":"publisher","unstructured":"Dixon, G. et al. QSER1 protects DNA methylation valleys from de novo methylation. Science https:\/\/doi.org\/10.1126\/science.abd0875 (2021).","DOI":"10.1126\/science.abd0875"},{"key":"370_CR74","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1101\/gr.172015.114","volume":"24","author":"W Yu","year":"2014","unstructured":"Yu, W. et al. Genome-wide DNA methylation patterns in LSH mutant reveals de-repression of repeat elements and redundant epigenetic silencing pathways. Genome Res. 24, 1613\u20131623 (2014).","journal-title":"Genome Res."},{"key":"370_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"370_CR76","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z. & Zhang, B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 47, W199\u2013w205 (2019).","journal-title":"Nucleic Acids Res."},{"key":"370_CR77","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50, 163\u2013170 (1966).","journal-title":"Cancer Chemother. Rep."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-022-00370-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-022-00370-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-022-00370-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:57:59Z","timestamp":1669352279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-022-00370-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":77,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1038\/s43018-022-00370-5","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"assertion":[{"value":"18 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.M. is co-inventor on a patent related to hypermethylated CGI targets in cancer. A.M. is a co-founder and scientific advisor of Harbinger Health. A.M. is part of the scientific advisory board of Zymo Research. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}